
501 - 1000 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
Biotechnology • Pharmaceuticals
Denali Therapeutics is a biopharmaceutical company developing therapies for serious neurological and neurodegenerative diseases. The company uses a proprietary TransportVehicle™ platform to deliver therapeutics (including across the blood-brain barrier) and advances a pipeline of clinical-stage products; its product tividenofusp alfa-eknm (AVLAYAH™) is now approved in the U. S. Denali provides information for patients and medical professionals, runs clinical studies and early access programs, and engages in partnerships, grants, and publications.
🕒 July 17
Director leading Patient Access & Experience in a biotech company focused on therapies for neurodegenerative diseases. Managing field teams and ensuring high-quality patient support throughout the treatment journey.